Irlanda - inglese - HPRA (Health Products Regulatory Authority)

torbet laboratories limited - cetrimonium bromide chlorhexidine gluconate - cutaneous solution

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

leo laboratories limited - cetrimonium bromide - cream

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

foran chemicals ltd - cetrimonium bromide benzalkonium chloride - cutaneous spray solution - ovine - antiseptics

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza virus, types a and b in adults and children older than 6 months in accordance with the recommendations in the national immunisation guideline.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

novartis vaccines & diagnostics pty ltd - influenza virus haemagglutinin -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin -

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238)); influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237)); influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26)); influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type)) - suspension for injection - 0.5 ml - active: influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238)) influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237)) influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26)) influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild type)) excipient: calcium chloride dihydrate dibasic sodium phosphate as dihydrate 0.67 mg magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza caused by influenza virus, types a and b. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines. influvac tetra is indicated in adults and children from 6 months of age and older.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - influenza virus haemagglutinin -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - influenza virus haemagglutinin -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

mylan health pty ltd - influenza virus haemagglutinin -